One way ANOVA Factor:epoch | Peak velocity | RMS Displ | V100 | V200 | Onset latency |
---|---|---|---|---|---|
Controls: | |||||
(df=1, 6) | F=3.37 | F=0.573 | F=1.736 | F=3.005 | F=0.013 |
PRD1 | p=0.116 | p=0.478 | p=0.236 | p=0.134 | p=0.915 |
NPD | F=0.871 | F=5.043 | F=5.712 | F=0.982 | F=1.723 |
PRD2 | p=0.387 | p=0.066 | p=0.054 | p=0.36 | p=0.237 |
Patients with Parkinson’s disease: | F=0.254 | F=0.159 | F=6.448 | F=2.016 | F=0.059 |
(df=1, 6) | p=0.633 | p=0.704 | p=0.0443-150 | p=0.205 | p=0.816 |
PRD1 | F=0.26 | F=1.263 | F=0.889 | F=0.026 | F=4.166 |
NPD | p=0.629 | p=0.304 | p=0.382 | p=0.877 | p=0.087 |
PRD2 | F=6.26 | F=3.101 | F=0.305 | F=0.045 | F=1.718 |
p=0.0463-150 | p=0.129 | p=0.601 | p=0.84 | p=0.238 | |
F=10.435 | F=6.73 | F=0.355 | F=3.392 | F=6.234 | |
p=0.0183-150 | p=0.0413-150 | p=0.573 | p=0.115 | p=0.0473-150 |
↵3-150 p<0.05.